Prokaryoplankton genomes from the deep marine sediments are much less explored in comparison with shallow shore sediments. The Gulfs of Kathiawar peninsula expertise various currents and inputs from completely different on-shore actions. Any perturbations would straight affect the microbiome and their regular homeostasis.
Developments in reconstructing genomes from metagenomes permits us to know the position of particular person unculturable microbes in ecological niches just like the Gulf sediments. Right here, we report 309 bacterial and archaeal genomes assembled from metagenomics knowledge of deep sediments from websites within the Gulf of Khambhat and Gulf of Kutch in addition to a pattern from the Arabian Sea. Phylogenomics labeled them into 5 archaeal and 18 bacterial phyla. The genomes will facilitate understanding of the physiology, adaptation and influence of on-shore anthropogenic actions on the deep sediment microbes.
Growing Bioprospecting Methods for Bioplastics By the Giant-Scale Mining of Microbial Genomes
The buildup of petroleum-based plastic waste has change into a significant situation for the setting. A sustainable and biodegradable resolution will be present in Polyhydroxyalkanoates (PHAs), a microbially produced biopolymer. An evaluation of the worldwide phylogenetic and ecological distribution of potential PHA producing micro organism and archaea was carried out by mining a world genome repository for PHA synthase (PhaC), a key enzyme concerned in PHA biosynthesis.
Micro organism from the phylum Actinobacteria had been discovered to comprise the PhaC Class II genotype which produces medium-chain size PHAs, a physiology till now solely discovered inside a number of Pseudomonas species. Additional, a number of PhaC genotypes had been found inside Thaumarchaeota, an archaeal phylum with poly-extremophiles and the power to effectively use CO2 as a carbon supply, a major ecological group which have to date been little studied for PHA manufacturing. Bacterial and archaeal PhaC genotypes had been additionally noticed in excessive salinity and alkalinity circumstances, in addition to high-temperature geothermal ecosystems.
These genome mining efforts uncovered beforehand unknown candidate taxa for biopolymer manufacturing, in addition to microbes from environmental niches with properties that might doubtlessly enhance PHA manufacturing. This in silico examine gives priceless insights into distinctive PHA producing candidates, supporting future bioprospecting efforts towards higher focused and related taxa to additional improve the range of exploitable PHA manufacturing programs.
Geography, Host Genetics, and Cross-Area Microbial Networks Construction the Pores and skin Microbiota of Fragmented Brazilian Atlantic Forest Frog Populations
The host-associated microbiome performs a major position in well being. Nonetheless, the roles of things corresponding to host genetics and microbial interactions in figuring out microbiome range stay unclear. We examined these components utilizing amplicon-based sequencing of 175 Thoropa taophora frog pores and skin swabs collected from a naturally fragmented panorama in southeastern Brazil.
Particularly, we examined (1) the results of geography and host genetics on microbiome range and construction; (2) the construction of microbial eukaryotic and bacterial co-occurrence networks; and (3) co-occurrence between microeukaryotes with bacterial OTUs identified to have an effect on progress of the fungal pathogen Batrachochytrium dendrobatidis (Bd).
Whereas bacterial alpha range various by each web site kind and host MHC IIB genotype, microeukaryotic alpha range various solely by web site kind. Nonetheless, micro organism and microeukaryote composition confirmed variation in line with each web site kind and host MHC IIB genotype. Our community evaluation confirmed the best connectivity when each eukaryotes and micro organism had been included, implying that ecological interactions might happen amongst domains.
Lastly, anti-Bd micro organism weren’t broadly negatively co-associated with the fungal microbiome and had been positively related to potential amphibian parasites. Our findings emphasize the significance of contemplating each domains in microbiome analysis and recommend that for efficient probiotic methods for amphibian illness administration, contemplating potential interactions amongst all members of the microbiome is essential.
Eight metagenome-assembled genomes present proof for microbial adaptation in 20,000 to 1,000,000-year-old Siberian permafrost
Permafrost microbes could also be metabolically energetic in microscopic layers of liquid brines, even in historical soil. Metagenomics can assist discern whether or not permafrost microbes present variations to this setting. Thirty-three metagenome-assembled genomes (MAGs) had been obtained from six depths (3.5 m to 20 m) of freshly-cored permafrost from the Siberia Kolyma-Indigirka Lowland area. These soils have been constantly frozen for ∼20,000 to 1,000,000 years.
Eight of those MAGs had been ≥80% full with <10% contamination and had been taxonomically recognized as Aminicenantes, Atribacteria, Chloroflexi, and Actinobacteria inside micro organism and Thermoprofundales inside archaea. MAGs from these taxa have beforehand been obtained from non-permafrost environments and have been prompt to point out variations to long-term energy-starvation, however they’ve by no means been explored in historical permafrost. The permafrost MAGs had greater proportions of clusters of orthologous genes (COGs) from ‘Vitality manufacturing and conversion’ and ‘Carbohydrate transport and metabolism’ than their non-permafrost counterparts.
Additionally they contained genes for trehalose synthesis, thymine metabolism, mevalonate biosynthesis and cellulose degradation that had been much less prevalent in non-permafrost genomes. Many of those genes are concerned in membrane stabilization and osmotic stress responses, in step with adaptation to the anoxic, excessive ionic energy, chilly environments of permafrost brine movies. Our outcomes recommend that this historical permafrost comprises DNA in excessive sufficient high quality to assemble MAGs from microorganisms with variations to subsist long-term freezing on this excessive setting. Significance Permafrost all over the world is thawing quickly.
Anti-Human TNFSF5 (CD40 Ligand) Antibody |
|||
| 101-M849 | ReliaTech | 100 µg | EUR 399 |
|
Description: CD40 ligand (CD40L), also known as CD154, TNFSF5, TRAP or gp39, is a 260 amino acid type II transmembrane glycoprotein belonging to the TNF family. Murine CD40L consists of a 22 aa cytoplasmic domain, a 24 aa transmembrane domain, and 214 aa extracellular domain bearing a single glycosylation site. CD40L is expressed predominantly on activated CD4+ T lymphocytes, and also found in other types of cells, including NK cells, mast cells, basophils and eosinophils. Murine CD40L shares 78% amino acid sequence identity with human CD40L. Native bioactive soluble CD40L exists. Soluble human trimeric CD40L secreted by stimulated T cells has been shown to be generated by proteolysis in the microsomes. Both membrane bound and soluble CD40L induce similar effects on B cells. |
|||
Anti-Human CD154/CD40LG/TNFSF5 Nanobody |
|||
| MBS1568075-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Human CD154/CD40LG/TNFSF5 Nanobody |
|||
| MBS1568075-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Human sCD40L/ TNFSF5 ELISA KIT |
|||
| E42EH-225 | EnoGene | 96T/48T | EUR 795 |
Anti-Human CD154/CD40LG/TNFSF5 Antibody (5C8) |
|||
| MBS1564348-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Human CD154/CD40LG/TNFSF5 Antibody (5C8) |
|||
| MBS1564348-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
TNFSF5 Antibody |
|||
| GWB-4527AE | GenWay Biotech | 0.025 mg | Ask for price |
Anti-Human CD154/CD40LG/TNFSF5 Antibody (hu5c8) |
|||
| MBS1564347-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Human CD154/CD40LG/TNFSF5 Antibody (hu5c8) |
|||
| MBS1564347-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Mouse Monoclonal anti-human TNFSF5 (CD40 Ligand) |
|||
| hAP-0173 | Angio Proteomie | 100ug | EUR 250 |
Mouse Monoclonal anti-human TNFSF5 (CD40 Ligand) |
|||
| hAP-0173A | Angio Proteomie | 100ug | EUR 250 |
Sheep Polyclonal anti-Human TNFSF5 (CD40 Ligand) |
|||
| hAP-5652 | Angio Proteomie | 50ug | EUR 400 |
Recombinant Human TNFSF5/CD40 Ligand Protein |
|||
| RP01082 | Abclonal | 10 μg | EUR 205.47 |
Human CellExp? CD40 Ligand / TNFSF5, Human Recombinant |
|||
| P1174-10 | Biovision | each | EUR 196.8 |
Human CellExp? CD40 Ligand / TNFSF5, Human Recombinant |
|||
| P1174-50 | Biovision | each | EUR 666 |
Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| CI56-10ug | Novoprotein | 10ug | EUR 175.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| CI56-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| CI56-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| CI56-50ug | Novoprotein | 50ug | EUR 363.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 |
|||
| AP76030 | SAB | 1mg | EUR 3209 |
Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-001mg | MyBiosource | 0.01mg | EUR 265 |
Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-002mg | MyBiosource | 0.02mg | EUR 360 |
Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-005mg | MyBiosource | 0.05mg | EUR 450 |
Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-01mg | MyBiosource | 0.1mg | EUR 670 |
Recombinant human CD40 Ligand/TNFSF5 protein |
|||
| MBS201332-025mg | MyBiosource | 0.25mg | EUR 1075 |
Recombinant Human CD40L/CD154/TNFSF5 Protein |
|||
| MBS2557334-002mg | MyBiosource | 0.02mg | EUR 270 |
Recombinant Human CD40L/CD154/TNFSF5 Protein |
|||
| MBS2557334-01mg | MyBiosource | 0.1mg | EUR 690 |
Recombinant Human CD40L/CD154/TNFSF5 Protein |
|||
| MBS2557334-5x01mg | MyBiosource | 5x0.1mg | EUR 3105 |
Human CD40 Ligand/TNFSF5 Recombinant Protein |
|||
| PROTP29965 | BosterBio | Regular: 50ug | EUR 250 |
|
Description: Human CD40 Ligand/TNFSF5 Recombinant Protein expressed in E. coli with His-tag. Sequence domain: 113-261aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method). |
|||
Recombinant Human TNFSF5/CD40 ligand/CD154 Protein |
|||
| RP01733 | Abclonal | 20μg | EUR 74.39 |
Recombinant Human TNFSF5/CD40 Ligand Trimer Protein |
|||
| RP02040 | Abclonal | 100μg | EUR 325.91 |
Recombinant Human TNFSF5/CD40 Ligand Trimer Protein |
|||
| RP02053 | Abclonal | 100μg | EUR 325.91 |
Recombinant Human CD40L/TNFSF5 Protein (His Tag) |
|||
| PKSH033726-10ug | Elabscience Biotech | 10ug | EUR 92 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5 Protein (His Tag) |
|||
| PKSH033726-50ug | Elabscience Biotech | 50ug | EUR 214 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5 Protein (Human Cells)(Active) |
|||
| PKSH032214-10ug | Elabscience Biotech | 10ug | EUR 117 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5 Protein (Human Cells)(Active) |
|||
| PKSH032214-50ug | Elabscience Biotech | 50ug | EUR 297 |
|
Description: Human |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 Protein |
|||
| MBS2552473-001mg | MyBiosource | 0.01mg | EUR 170 |
Recombinant Human CD40 Ligand/CD40L/TNFSF5 Protein |
|||
| MBS2552473-005mg | MyBiosource | 0.05mg | EUR 305 |
Recombinant Human CD40 Ligand/CD40L/TNFSF5 Protein |
|||
| MBS2552473-5x005mg | MyBiosource | 5x0.05mg | EUR 1365 |
Recombinant Human CD40L/TNFSF5 Protein (E.coli)(Active) |
|||
| PKSH033725-100ug | Elabscience Biotech | 100ug | EUR 739 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5 Protein (E.coli)(Active) |
|||
| PKSH033725-20ug | Elabscience Biotech | 20ug | EUR 249 |
|
Description: Human |
|||
Human CellExp? CD40 Ligand / TNFSF5, Fc tag, Human Recombinant |
|||
| P1175-10 | Biovision | each | EUR 196.8 |
Human CellExp? CD40 Ligand / TNFSF5, Fc tag, Human Recombinant |
|||
| P1175-50 | Biovision | each | EUR 666 |
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| AP74776 | SAB | 1mg | EUR 1369 |
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-10ug | Novoprotein | 10ug | EUR 120 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-1mg | Novoprotein | 1mg | EUR 1131.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-500ug | Novoprotein | 500ug | EUR 808.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L/TNFSF5 (E. coli) |
|||
| C011-50ug | Novoprotein | 50ug | EUR 230.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 200mM NaCl, 0.1mM EDTA, pH 7.0. |
|||
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| MBS2569051-001mg | MyBiosource | 0.01mg | EUR 165 |
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| MBS2569051-005mg | MyBiosource | 0.05mg | EUR 320 |
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| MBS2569051-5x005mg | MyBiosource | 5x0.05mg | EUR 1430 |
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| PKSH033868-10ug | Elabscience Biotech | 10ug | EUR 104 |
|
Description: Human |
|||
Recombinant Human CD40 Ligand/CD40L//TNFSF5 (N-mFc) |
|||
| PKSH033868-50ug | Elabscience Biotech | 50ug | EUR 312 |
|
Description: Human |
|||
Recombinant Human CD40L/CD154/TNFSF5/Protein (His Tag) |
|||
| MBS2552272-01mg | MyBiosource | 0.1mg | EUR 630 |
Recombinant Human CD40L/CD154/TNFSF5/Protein (His Tag) |
|||
| MBS2552272-1mg | MyBiosource | 1(mg) | EUR 4115 |
Recombinant Human CD40L/CD154/TNFSF5/Protein (His Tag) |
|||
| MBS2552272-5x1mg | MyBiosource | 5x1mg | EUR 18515 |
Recombinant Human CD40L/CD154/TNFSF5 Protein (N-His) |
|||
| MBS2557335-001mg | MyBiosource | 0.01mg | EUR 155 |
Recombinant Human CD40L/CD154/TNFSF5 Protein (N-His) |
|||
| MBS2557335-005mg | MyBiosource | 0.05mg | EUR 240 |
Recombinant Human CD40L/CD154/TNFSF5 Protein (N-His) |
|||
| MBS2557335-5x005mg | MyBiosource | 5x0.05mg | EUR 1080 |
Recombinant Human CD40L/TNFSF5 Protein (His Tag)(Active) |
|||
| PKSH031976-100ug | Elabscience Biotech | 100ug | EUR 670 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5 Protein (His Tag)(Active) |
|||
| PKSH031976-1mg | Elabscience Biotech | 1mg | EUR 4715 |
|
Description: Human |
|||
CD40 Ligand/TNFSF5 |
|||
| E21-011 | EnoGene | 10ug | EUR 225 |
|
Description: Recombinant Human CD40 Ligand is produced by our E.coli expression system and the target gene encoding Met113-Leu261 is expressed. |
|||
CD154/CD40L/TNFSF5 |
|||
| E21-I56 | EnoGene | 10ug | EUR 225 |
|
Description: Recombinant Human CD40 Ligand is produced by our Mammalian expression system and the target gene encoding Met113-Leu261 is expressed. |
|||
TNFSF5 (CD40 Ligand) |
|||
| MBS692711-01mg | MyBiosource | 0.1mg | EUR 725 |
TNFSF5 (CD40 Ligand) |
|||
| MBS692711-5x01mg | MyBiosource | 5x0.1mg | EUR 2965 |
CD40 Ligand/TNFSF5 |
|||
| MBS8532832-001mg | MyBiosource | 0.01mg | EUR 305 |
CD40 Ligand/TNFSF5 |
|||
| MBS8532832-5x001mg | MyBiosource | 5x0.01mg | EUR 1220 |
CD154/CD40L/TNFSF5 |
|||
| MBS8532979-001mg | MyBiosource | 0.01mg | EUR 305 |
CD154/CD40L/TNFSF5 |
|||
| MBS8532979-5x001mg | MyBiosource | 5x0.01mg | EUR 1220 |
Recombinant Human CD40 Ligand/CD154/CD40L/TNFSF5 Protein |
|||
| RP00329 | Abclonal | 10μg | EUR 134.62 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-1mg |
|||
| QP8528-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Anti-Mouse CD154/CD40L/TNFSF5 Antibody (MR1/MR-1) |
|||
| MBS1569703-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Mouse CD154/CD40L/TNFSF5 Antibody (MR1/MR-1) |
|||
| MBS1569703-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-10ug |
|||
| QP8528-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-50ug |
|||
| QP8528-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-1mg |
|||
| QP9047-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-100ug |
|||
| QP8528-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-200ug |
|||
| QP8528-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, GST, E.coli-500ug |
|||
| QP8528-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-10ug |
|||
| QP9047-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-50ug |
|||
| QP9047-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-100ug |
|||
| QP9047-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-200ug |
|||
| QP9047-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, His, Yeast-500ug |
|||
| QP9047-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
CD40LG/TNFSF5 (Cd40 Ligand) Antibody |
|||
| 20-abx111483 | Abbexa |
|
|
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065933-100g | Abbexa | 100 µg | EUR 475 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065933-10g | Abbexa | 10 µg | EUR 200 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065933-50g | Abbexa | 50 µg | EUR 337.5 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065936-100g | Abbexa | 100 µg | EUR 475 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065936-10g | Abbexa | 10 µg | EUR 200 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx065936-50g | Abbexa | 50 µg | EUR 337.5 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx168182-1ml | Abbexa | 1 ml | EUR 225 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Protein |
|||
| abx670194-50g | Abbexa | 50 µg | EUR 487.5 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-1mg |
|||
| QP5332-1mg | EnQuireBio | 1mg | EUR 1633.2 |
Human CD40 Ligand/TNFSF5/CD40LG PicoKine® Quick ELISA Kit |
|||
| FEK0573 | BosterBio | 96 wells/kit, with removable strips. | EUR 499 |
|
Description: Human CD40 Ligand/TNFSF5/CD40LG PicoKine® Quick ELISA Kit (90 minutes, 96 Tests). Quantitate Human CD40 Ligand/TNFSF5/CD40LG in cell culture supernatants, cell lysates, serum and plasma (heparin, EDTA). Sensitivity: 15 pg/ml. |
|||
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-10ug |
|||
| QP10359-ec-10ug | EnQuireBio | 10ug | EUR 184.8 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-50ug |
|||
| QP10359-ec-50ug | EnQuireBio | 50ug | EUR 348 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-100ug |
|||
| QP10359-ec-100ug | EnQuireBio | 100ug | EUR 630 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-250ug |
|||
| QP10359-ec-250ug | EnQuireBio | 250ug | EUR 1077.6 |
Recombinant Human CD40L/ CD154/ TNFSF5 Protein, Untagged, E.coli-500ug |
|||
| QP5332-500ug | EnQuireBio | 500ug | EUR 991.2 |
Biotinylated Human CD40 Ligand / TNFSF5 Protein, Avitag™,Fc Tag |
|||
| CDL-H82F1 | ACROBIOSYSTEMS | 25ug | EUR 1678.6 |
|
Description: Biotinylated Human CD40 Ligand, Avitag,Fc Tag (CDL-H82F1) is expressed from human 293 cells (HEK293). It contains AA Met 113 - Leu 261 (Accession # P29965-1). |
|||
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) CLIA Kit |
|||
| MBS2532255-5x96Tests | MyBiosource | 5x96Tests | EUR 2565 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) CLIA Kit |
|||
| MBS2532255-96Tests | MyBiosource | 96Tests | EUR 560 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) CLIA Kit |
|||
| abx195380-96tests | Abbexa | 96 tests | EUR 618.75 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) CLIA Kit |
|||
| 20-abx491058 | Abbexa |
|
|
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-10x96Tests | MyBiosource | 10x96Tests | EUR 4060 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-24Tests | MyBiosource | 24Tests | EUR 265 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-48Test | MyBiosource | 48Test | EUR 450 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-5x96Test | MyBiosource | 5x96Test | EUR 2265 |
Human CD40L/TNFSF5 (Cluster of Differentiation 40 Ligand) ELISA Kit |
|||
| MBS2514250-96Tests | MyBiosource | 96Tests | EUR 535 |
Human CellExp? CD40 Ligand / TNFSF5 Protein, Fc Tag, Mouse recombinant |
|||
| P1127-10 | Biovision | each | EUR 170.4 |
Human CellExp? CD40 Ligand / TNFSF5 Protein, Fc Tag, Mouse recombinant |
|||
| P1127-50 | Biovision | each | EUR 574.8 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx050201-96tests | Abbexa | 96 tests | EUR 924 |
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| 20-abx151003 | Abbexa |
|
|
Human Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) ELISA Kit |
|||
| abx250223-96tests | Abbexa | 96 tests | EUR 801.6 |
Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| MBS2569199-002mg | MyBiosource | 0.02mg | EUR 350 |
Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| MBS2569199-01mg | MyBiosource | 0.1mg | EUR 855 |
Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| MBS2569199-5x01mg | MyBiosource | 5x0.1mg | EUR 3835 |
Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| PKSH034016-100ug | Elabscience Biotech | 100ug | EUR 924 |
|
Description: Human |
|||
Recombinant Human CD40L/TNFSF5/CD40 Ligand (N-6His-Avi) Biotinylated |
|||
| PKSH034016-20ug | Elabscience Biotech | 20ug | EUR 342 |
|
Description: Human |
|||
Human Anti-CD40L (CD40 Ligand, CD154, Tumor Necrosis Factor Ligand Superfamily Member 5, TNFSF5, Gp39, TRAP) |
|||
| MBS6120622-01mg | MyBiosource | 0.1(mg | EUR 650 |
Human Anti-CD40L (CD40 Ligand, CD154, Tumor Necrosis Factor Ligand Superfamily Member 5, TNFSF5, Gp39, TRAP) |
|||
| MBS6120622-5x01mg | MyBiosource | 5x0.1mg | EUR 2785 |
Human CD40 Ligand / TNFSF5 Protein, Fc Tag, active trimer (MALS verified) |
|||
| CDL-H5269 | ACROBIOSYSTEMS | 100ug | EUR 2932.1 |
|
Description: Human CD40 Ligand, Fc Tag (active trimer) (MALS verified) (CDL-H5269) is expressed from human 293 cells (HEK293). It contains AA Gly 116 - Leu 261 (Accession # P29965-1) trimer Design. |
|||
Recombinant (E.coli) Human CD40 Ligand/CD40L/TNFSF5 (aa:108-261, His Tag, >95% Pure) |
|||
| HCD40L-15-N-10 | Alpha Diagnostics | 10 ug | EUR 255.6 |
Human CD40 Ligand / TNFSF5 Protein, His,Flag Tag, active trimer (MALS verified) |
|||
| CDL-H52Db | ACROBIOSYSTEMS | 100ug | EUR 2801.3 |
|
Description: Human CD40 Ligand, His,Flag Tag (CDL-H52Db) is expressed from human 293 cells (HEK293). It contains AA Gly 116 - Leu 261 (Accession # P29965-1) trimer Design. |
|||
Human CD40 Ligand / TNFSF5 Protein, His,Flag Tag, active trimer (MALS verified) |
|||
| CDL-H52Db-100ug | ACROBIOSYSTEMS | 100ug | EUR 381.5 |
|
Description: Human CD40 Ligand, His,Flag Tag (CDL-H52Db) is expressed from human 293 cells (HEK293). It contains AA Gly 116 - Leu 261 (Accession # P29965-1) trimer Design. |
|||
Human CD40 Ligand / TNFSF5 Protein, His,Flag Tag, active trimer (MALS verified) |
|||
| CDL-H52Db-1mg | ACROBIOSYSTEMS | 1mg | EUR 2801.3 |
|
Description: Human CD40 Ligand, His,Flag Tag (CDL-H52Db) is expressed from human 293 cells (HEK293). It contains AA Gly 116 - Leu 261 (Accession # P29965-1) trimer Design. |
|||
Mouse CD40 Ligand/TNFSF5 ELISA kit |
|||
| E22-MC042.48 | EnoGene | 48T | EUR 495 |
Mouse CD40 Ligand/TNFSF5 ELISA kit |
|||
| E22-MC042.96 | EnoGene | 96T | EUR 595 |
Anti-TRAIL (human) TNFSF10 Antibody |
|||
| A00466-2 | BosterBio | 100ul | EUR 384 |
|
Description: Boster Bio Anti-TRAIL (human) TNFSF10 Antibody catalog # A00466-2. Tested in IF, IHC applications. This antibody reacts with Human. |
|||
Anti Human TNFSF13 Polyclonal Antibody |
|||
| Y054783 | ABM | 100 µl | EUR 575 |
Human / Rhesus macaque CD40 Ligand / TNFSF5 Protein, Mouse IgG2a Fc Tag, low endotoxin |
|||
| CDL-H5256 | ACROBIOSYSTEMS | 100ug | EUR 2398 |
|
Description: Human / Rhesus macaque CD40 Ligand, Mouse IgG2a Fc Tag, low endotoxin (CDL-H5256) is expressed from human 293 cells (HEK293). It contains AA Met 113 - Leu 261 (Accession # P29965-1). In the region Met 113 - Leu 261, the AA sequence of Human and Rhesus macaque CD40 Ligand are homologus. |
|||
Mouse CD40 Ligand/TNFSF5 Recombinant Protein |
|||
| PROTP27548 | BosterBio | Regular: 25ug | EUR 350 |
|
Description: Mouse CD40 Ligand/TNFSF5 Recombinant Protein expressed in Baculovirus with His-tag. Sequence domain: 112-260aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method). |
|||
Recombinant Mouse CD40 Ligand/TNFSF5 Protein |
|||
| RP00792 | Abclonal | 10μg | EUR 138.16 |
Mouse CD40 Ligand / TNFSF5 Protein, Fc Tag |
|||
| CDL-M526x | ACROBIOSYSTEMS | 1mg | EUR 327 |
|
Description: Mouse CD40 Ligand, Fc Tag (CDL-M526x) is expressed from human 293 cells (HEK293). It contains AA Gly 115 - Leu 260 (Accession # P27548-1). |
|||
Human Rhesus macaque CD40 Ligand / TNFSF5 Recombinant Protein Mouse IgG Fc Tag Lyophilized |
|||
| IHUMNRSCD40LGTNFSF5RMSIGGFCLY100UG | Innovative research | each | EUR 762 |
|
Description: Human Rhesus macaque CD40 Ligand / TNFSF5 Recombinant Protein Mouse IgG Fc Tag Lyophilized |
|||
Human Rhesus macaque CD40 Ligand/TNFSF5 Recombinant Protein Mouse IgG Fc Tag Lyophilized |
|||
| MBS8432791-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti Human TNFSF14:Preservative Free |
|||
| MBS226242-01mg | MyBiosource | 0.1mg | EUR 440 |
Rabbit anti Human TNFSF14:Preservative Free |
|||
| MBS226242-5x01mg | MyBiosource | 5x0.1mg | EUR 1805 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx021416-400l | Abbexa | 400 µl | Ask for price |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx021416-80l | Abbexa | 80 µl | EUR 1225 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx000686-100l | Abbexa | 100 µl | EUR 400 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx000686-20l | Abbexa | 20 µl | EUR 175 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx000686-50l | Abbexa | 50 µl | EUR 275 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx111483-100l | Abbexa | 100 µl | EUR 612.5 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx128008-100l | Abbexa | 100 µl | EUR 250 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx128008-1ml | Abbexa | 1 ml | EUR 675 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx128008-200l | Abbexa | 200 µl | EUR 312.5 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx131772-100g | Abbexa | 100 µg | EUR 775 |
Cluster of Differentiation 40 Ligand / TNFSF5 (CD40LG) Antibody |
|||
| abx131772-20g | Abbexa | 20 µg | EUR 350 |
Many scientists from a wide range of disciplines have proven the significance of understanding what is going to occur to our ecosystem, commerce, and local weather when permafrost thaws. The destiny of permafrost microorganisms is related to those predicted speedy environmental modifications. Finding out historical permafrost with tradition unbiased strategies may give a glimpse into how these microorganisms operate in these excessive low temperature and vitality circumstances. This can help understanding of how they are going to change with the setting. This examine presents genomic knowledge from this distinctive setting aged ∼20,000 to 1,000,000-years-old.